Advertisement
UK markets open in 5 hours 41 minutes

  • NIKKEI 225

    37,996.37
    -463.71 (-1.21%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • CRUDE OIL

    82.66
    -0.15 (-0.18%)
     

  • GOLD FUTURES

    2,330.00
    -8.40 (-0.36%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,730.88
    -1,814.71 (-3.39%)
     

  • CMC Crypto 200

    1,394.61
    -29.49 (-2.07%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Why Arrowhead Pharmaceuticals Stock Jumped Today

Prosper Junior Bakiny, The Motley Fool
·2-min read
Why Arrowhead Pharmaceuticals Stock Jumped Today

Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) rose sharply on Thursday and closed today's trading session up 9.9% after climbing by as much as 14.4%. The drugmaker did not report any news, but biotech giant Vertex Pharmaceuticals (NASDAQ:VRTX) released an update regarding one of its pipeline candidates, and the update bodes well for Arrowhead and its shareholders. On Wednesday evening, Vertex announced it would discontinue the development of VX-814, a potential treatment for alpha-1 antitrypsin deficiency (AATD), a genetic condition that can cause lung or liver disease.

Continue reading